PALO ALTO, Calif.- January 6, 2020—Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco. ● Brent Vaughan, CEO and co-founder of Cognoa, will provide an update on the company’s milestones and strategy at the Digital Medicine & Medtech Showcase™ 2020,…
Cognoa launches a pivotal study to demonstrate the effectiveness of its diagnostic aid for autism spectrum disorder (ASD). Read article here.
by Elaine Roth There was no preparation for the transition into lockdown. One day, COVID-19 was a vague virus I was reading about in the news, and the next, it was here—in my small town, in my schools. And everything shut down with alarming speed. The change to stay-at-home life happened almost literally overnight for my kids. We had no time to plan. The…
Researchers and advocates have convincingly shown that the wide gap in diagnoses between boys and girls isn’t simply a matter of boys being significantly more likely to be on the autism spectrum. By DAVID HAPPEL Statistically, boys are four times as likely as girls to receive a diagnosis of autism spectrum disorder (ASD). But that’s not because boys are four times as likely to have ASD. According…
Even as households worldwide self-isolate to help curb the spread of the novel coronavirus, we’re the furthest thing from isolated when it comes to what we’re experiencing—starting from the shared stress and concern we’re feeling amid such significant upheaval and uncertainty. For families with a child on the autism spectrum, these times can be uniquely concerning. Disruption to autism spectrum disorder (ASD)…
Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries. (Palo Alto, Calif. – March 24, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today the appointment of David Happel as Chief Executive Officer. Cognoa’s former CEO…
An Interview with Cognoa’s CEO Brent Vaughan In the US, one in five children are living with a diagnosable behavioral health disorder; however, only 21% of those children who are diagnosed receive needed treatment. Often, parents have to wait one to three years to receive a proper and accurate diagnosis, and an individualized treatment plan for their child. For the last 15 years, the average…
Halim Abbas, Ford Garberson, Stuart Liu-Mayo, Eric Glover & Dennis P. Wall Scientific Reports volume 10, Article number: 5014 (2020) Cite this article 2 Altmetric | Metricsdetails Abstract Autism has become a pressing healthcare challenge. The instruments used to aid diagnosis are time and labor expensive and require trained clinicians to administer, leading to long wait times for at-risk children. We present a multi-modular, machine learning-based assessment of autism comprising three complementary modules…
Ronit Molko, Ph.D., BCBA-D describes how AI will become the norm of autism services, as it has in other industries, including Cognoa’s digital therapeutics that create a more proactive role for parents and pediatricians in the diagnostic and treatment processes to accomplish early intervention. Read full article here.
AAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps (Palo Alto, Calif.– March 5, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that renowned pediatrician and 2018 Past President of the American Academy of Pediatrics (AAP), Dr. Colleen…
PALO ALTO, Calif. — February 26, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives from Akili Interactive Labs, Click Therapeutics and Pear Therapeutics. The panel will take place at 1:30…
Pediatric digital therapeutics developer Cognoa has teamed up with Autism Learning Partners, a specialized treatment provider, to put its autism screening app in the hands of parents to help track their children’s development. Read the full article here.
